Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects

DEFRONZO, RALPH A., BARZILAI, NIR, SIMONSON, DONALD C. · 1991 · The Journal of Clinical Endocrinology & Metabolism

Abstract

The effect of metformin on glucose metabolism was examined in eight obese (percent ideal body weight, 151 +/- 9%) and six lean (percent ideal body weight, 104 +/- 4%) noninsulin-dependent diabetic (NIDD) subjects before and after 3 months of metformin treatment (2.5 g/day). Fasting plasma glucose (11.5-8.8 mmol/L), hemoglobin-A1c (9.8-7.7%), oral glucose tolerance test response (20.0-17.0 mmol/L; peak glucose), total cholesterol (5.67-4.71 mmol/L), and triglycerides (2.77-1.52 mmol/L) uniformly decreased (P less than 0.05-0.001) after metformin treatment; fasting plasma lactate increased slightly from baseline (1.4 to 1.7 mmol/L; P = NS). Body weight decreased by 5 kg in obese NIDD subjects, but remained constant in lean NIDD. Basal hepatic glucose production declined in all diabetics from 83 to 61 mg/m2.min (P less than 0.01), and the decrease correlated (r = 0.80; P less than 0.01) closely with the fall in fasting glucose concentration. Fasting insulin (115 to 79 pmol/L) declined (P less than 0.05) after metformin. During a 6.9 mmol/L hyperglycemic clamp, glucose uptake increased in every NIDD subject (113 +/- 15 to 141 +/- 12 mg/m2.min; P less than 0.001) without a change in the plasma insulin response. During a euglycemic insulin clamp, total glucose uptake rose in obese NIDD subjects (121 +/- 10 to 146 +/- 9 mmol/m2.min; P less than 0.05), but decreased slightly in lean NIDD (121 +/- 10 to 146 +/- 0.5; P = NS). Hepatic glucose production was suppressed by more than 80-90% in all insulin clamp studies before and after metformin treatment. In conclusion, metformin lowers the fasting plasma glucose and insulin concentrations, improves oral glucose tolerance, and decreases plasma lipid levels independent of changes in body weight. The improvement in fasting glucose results from a reduction in basal hepatic glucose production. Metformin per se does not enhance tissue sensitivity to insulin in NIDD subjects. The improvement in glucose metabolism under hyperglycemic, but not euglycemic, conditions suggests that metformin augments glucose-mediated glucose uptake. Metformin has no stimulatory effect on insulin secretion.

Overview

Integrity signals

Registry

Crossref · 10.1210/jcem-73-6-1294

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 39 references

Cited by

See all 408

Metadata

Authors
DEFRONZO, R. A., BARZILAI, N., & SIMONSON, D. C.
Affiliations
The University of Texas at San Antonio Health Science Center (US)
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
1991-12
Volume
73
Issue
6
Pages
1294-1301
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W1967943195
Cited by
408
References
39
Citations by year
2026: 5 · 2025: 5 · 2024: 7 · 2023: 9 · 2022: 6 · 2021: 13 · 2020: 10 · 2019: 13 · 2018: 10 · 2017: 11 · 2016: 8 · 2015: 13 · 2014: 12 · 2013: 14 · 2012: 11
FWCI
3.29
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
metformin, type 2 diabetes, obesity, glucose metabolism, hepatic glucose production, insulin sensitivity, glucose uptake, fasting blood glucose, insulin, hyperglycemic clamp, hyperinsulinemic-euglycemic clamp, plasma lipids, triglycerides, cholesterol, body weight, mechanism of action
MeSH terms
Blood Glucose, Body Weight, Diabetes Mellitus, Diabetes Mellitus, Type 2, Fasting, Female, Glucose, Glucose Tolerance Test, Humans, Insulin, Lactates, Lipids, Liver, Male, Metformin, Middle Aged, Obesity, Glucose Clamp Technique, Lactic Acid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects. https://app.cochat.ai/papers/10.1210/jcem-73-6-1294
The paper
DEFRONZO, R. A., BARZILAI, N., & SIMONSON, D. C. (1991). Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jcem-73-6-1294

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.